Scaling Your Biotech Startup? Haskell & White Has a Plan


By Carlos Martinez, Life Science LeaderĀ  March 1, 2019 Holding yourself to the financial standards of a public life sciences company when your venture is still private or even in the prerevenue stages might not seem like the top priority to many young companies, but looking at your business through the eyes of the Securities [...]